AstraZeneca PLC ADR



Market open

 --Real time quotes

Sep 20, 2021, 11:09 a.m.





+2.59 +4.65%


Volume 6.40m

Real time quotes


Previous close

$ 55.56

$ 58.15


+2.59 +4.65%

Day low

Day high




52 week low

52 week high




Annual Financials for AstraZeneca PLC ADR

Fiscal year is January-December. All values GBP millions. 20162017201820192020 5-year trend
Sales/Revenue 17.05B17.44B16.57B19.11B21.52B
Cost of Goods Sold (COGS) incl. D&A 4.13B4.52B4.68B5.28B5.59B
COGS excluding D&A 2.42B2.61B2.59B3.1B3.33B
Depreciation & Amortization Expense 1.71B1.9B2.08B2.18B2.26B
Depreciation 451.35M484.54M460.48M669.42M704.95M
Amortization of Intangibles 1.26B1.42B1.62B1.51B1.55B
Gross Income 12.92B12.93B11.89B13.83B15.93B
20162017201820192020 5-year trend
SG&A Expense 10.28B10.23B10.51B11.63B12.28B
Research & Development 4.17B4.2B3.95B4.17B4.75B
Other SG&A 6.1B6.03B6.57B7.46B7.53B
Other Operating Expense ---(3.14M)(8.58M)
Unusual Expense 836.73M1.72B835.46M1.48B348.58M
EBIT after Unusual Expense 1.8B979.95M541.47M725.07M3.3B
Non Operating Income/Expense 1.28B1.25B1.52B1.09B311.93M
Non-Operating Interest Income 31.87M54.36M72M96.41M31.97M
Equity in Affiliates (Pretax) -----
Interest Expense 457.27M515.6M555.72M605.14M573.94M
Gross Interest Expense 457.27M515.6M555.72M605.14M573.94M
Interest Capitalized -----
Pretax Income 2.66B1.77B1.58B1.3B3.07B
Income Tax 108.2M(497.74M)(42.75M)251.62M602.02M
Income Tax - Current Domestic 274.22M293.52M561.72M1.03B757.2M
Income Tax - Current Foreign -----
Income Tax - Deferred Domestic (166.01M)(791.26M)(604.47M)(774.45M)(155.18M)
Income Tax - Deferred Foreign -----
Income Tax Credits -----
Equity in Affiliates (24.46M)(42.71M)(84.75M)(90.93M)(21.06M)
Other After Tax Income (Expense) -----
Consolidated Net Income 2.52B2.23B1.54B961.8M2.45B
Minority Interest Expense (68.92M)(103.28M)(78.75M)(84.66M)(40.55M)
Net Income 2.59B2.33B1.62B1.05B2.49B
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries 2.59B2.33B1.62B1.05B2.49B
Preferred Dividends -----
Net Income Available to Common 2.59B2.33B1.62B1.05B2.49B
EPS (Basic) 2.051.841.280.801.90
Basic Shares Outstanding 1.27B1.27B1.27B1.3B1.31B
EPS (Diluted) 2.051.841.280.801.90
Diluted Shares Outstanding 1.27B1.27B1.27B1.3B1.31B
EBITDA 4.35B4.6B3.46B4.38B5.91B
Link to MarketWatch's Slice.